BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30

• Drug Development

  Array BioPharma, Inc. Release: Binimetinib And Encorafenib Combination Shows Promising Clinical Activity And Potential Differentiated Safety In BRAF-Mutant Melanoma

  June 1, 2015

   · 

  6 min read
• Drug Development

  ASCO15: Adaptimmune Announces Data From Clinical Studies Of NY-ESO-1 Specific T-Cells In Multiple Cancers At The 2015 Annual ASCO Meeting

  June 1, 2015

   · 

  7 min read
• Genetown

  Alere Declares Cash Dividend On Its Series B Convertible Perpetual Preferred Stock

  June 1, 2015

   · 

  1 min read
• Drug Development

  Caris Life Sciences Paired Tumor Data Identifies Key Driver Mutations And Confirms Tumor Heterogeneity In High-Grade Glioma Samples

  June 1, 2015

   · 

  5 min read
• Drug Development

  Pharmacyclics Release: Ibrutinib (IMBRUVICA) Phase Ib/II Data Show Promise In Patients With Chronic Graft-Versus-Host-Disease

  June 1, 2015

   · 

  12 min read
• Drug Development

  Amgen Initiates Phase 3 Study Evaluating Once-Weekly Kyprolis® (carfilzomib) in Patients With Relapsed And Refractory Multiple Myeloma

  June 1, 2015

   · 

  17 min read
• Drug Development

  ASCO15: AbbVie Presents Phase 2 Results From Study Of Investigational Medicine Veliparib In Patients With Non-Small Cell Lung Cancer At The American Society Of Clinical Oncology Annual Meeting

  June 1, 2015

   · 

  8 min read
• Drug Development

  ASCO15: Results From Phase 2 Study Of Lenvatinib When Combined With Everolimus In Metastatic Renal Cell Carcinoma To Be Presented In Oral Session At ASCO

  June 1, 2015

   · 

  9 min read
• Drug Development

  ASCO15: Celsion Corporation Presents GEN-1 Immunotherapy Phase 1b Results In Recurrent Ovarian Cancer At ASCO 2015

  June 1, 2015

   · 

  6 min read
• BioMidwest

  ASCO15: GenomeDx Biosciences’s Decipher Prostate Cancer Test Is Significant Predictor Of Metastasis In Patients With Detectable PSA Following Treatment With Radiation After Prostate Surgery, According To Study Presented At ASCO 2015 Annual Meeting

  June 1, 2015

   · 

  5 min read